In SVM models of three modalities, the sensitivities in predicting HER2-positive breast cancer were increased by CEUS, from 0.728 (95%CI: 0.554–0.862) to 0.778 (95%CI: 0.608–0.899). This evidence concerns the gene ERBB2 and breast cancer.